Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the dialysis outcomes and practice patterns study (DOPPS): Associations with mortality, patient characteristics, and facility practices

American Journal of Kidney Diseases

Volumn 57, Issue 2, 2011, Pages 266-275

  Pisoni, Ronald L ^a   Bragg Gresham, Jennifer L ^a   Fuller, Douglas S ^a   Morgenstern, Hal ^b   Canaud, Bernard ^c   Locatelli, Francesco ^d   Li, Yun ^b   Gillespie, Brenda ^b   Wolfe, Robert A ^a   Port, Friedrich K ^a   Robinson, Bruce M ^a  

^a ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c LAPEYRONIE HOSPITAL   (France)

^d A MANZONI HOSPITAL   (Italy)

Author keywords

Anemia; dialysis; DOPPS; hemodialysis; hemoglobin; international; management; mortality; practices; trends; variability

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL PRACTICE; MEDICARE; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; SPAIN; SURVIVAL; TREATMENT OUTCOME;

ANEMIA; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPAIN; SURVIVAL RATE; UNITED STATES;

EID: 78751624434     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.11.003     Document Type: Article

References (32)

1. G. Weiss, and L.T. Goodnough Anemia of chronic disease N Engl J Med 352 10 2005 1011 1023
2. C.P. Alfrey, and S. Fishbane Implications of neocytolysis for optimal management of anaemia in chronic kidney disease Nephron Clin Pract 106 4 2007 c149 c156
3. D.M. Spiegel, I. Khan, M. Krishnan, and T.J. Mayne Changes in hemoglobin level distribution in US dialysis patients from June 2006 to November 2008 Am J Kidney Dis 55 1 2009 113 120
4. National Kidney Foundation KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 update of hemoglobin target Am J Kidney Dis 50 3 2007 471 530
5. E. Lacson Jr, N. Ofsthun, and J.M. Lazarus Effect of variability in anemia management on hemoglobin outcomes in ESRD Am J Kidney Dis 41 1 2003 111 124
6. J.B. Wish Can evidence drive the development of a sound national EPO reimbursement policy? Am J Kidney Dis 41 1 2003 254 258
7. J.S. Berns, H. Elzein, R.I. Lynn, S. Fishbane, I.S. Meisels, and P.B. Deoreo Hemoglobin variability in epoetin-treated hemodialysis patients Kidney Int 64 4 2003 1514 1521
8. N.C. Boudville, O. Djurdjev, and I.C. Macdougall Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality Clin J Am Soc Nephrol 4 7 2009 1176 1182
9. W.G.E. Holzel Intra-individual variation of some analytes in serum patients with insulin-dependent diabetes mellitus Clin Chem 33 1 1987 57 61
10. B.E. Statland, P. Winkel, S.C. Harris, M.J. Burdsall, and A.M. Saunders Evaluation of biologic sources of variation of leukocyte counts and other hematologic quantities using very precise automated analyzers Am J Clin Pathol 69 1 1978 48 54
11. W. Yang, R.K. Israni, S.M. Brunelli, M.M. Joffe, S. Fishbane, and H.I. Feldman Hemoglobin variability and mortality in ESRD J Am Soc Nephrol 18 12 2007 3164 3170
12. S.M. Brunelli, K.E. Lynch, and E.D. Ankers Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients Clin J Am Soc Nephrol 3 6 2008 1733 1740
13. S.M. Brunelli, M.M. Joffe, and R.K. Israni History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients Clin J Am Soc Nephrol 3 3 2008 777 782
14. D.T. Gilbertson, J.P. Ebben, R.N. Foley, E.D. Weinhandl, B.D. Bradbury, and A.J. Collins Hemoglobin level variability: associations with mortality Clin J Am Soc Nephrol 3 1 2008 133 138
15. T.J. Arneson, D. Zaun, Y. Peng, C.A. Solid, S. Dunning, and D.T. Gilbertson Comparison of methodologies to characterize haemoglobin variability in the US Medicare haemodialysis population Nephrol Dial Transplant 24 5 2009 1378 1383
16. F. Locatelli, R.L. Pisoni, and C. Combe Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol Dial Transplant 19 1 2004 121 132
17. F.K. Port, R.L. Pisoni, and J. Bommer Improving outcomes for dialysis patients in the international Dialysis Outcomes and Practice Patterns Study Clin J Am Soc Nephrol 1 2 2006 246 255
18. E.W.G.D. Young, D.L. Mapes, and F.K. Port The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study Kidney Int Suppl 74 2000 74 81
19. R.L. Pisoni, B.W. Gillespie, D.M. Dickinson, K. Chen, M.H. Kutner, and R.A. Wolfe The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology Am J Kidney Dis 44 5 suppl 2 2004 S7 S15
20. M. Klein JaM Survival Analysis Techniques for Censored and Truncated Data 1997 Springer New York, NY
21. S. Fishbane, and J.S. Berns Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin Kidney Int 68 3 2005 1337 1343
22. D.T. Gilbertson, Y. Peng, B. Bradbury, J.P. Ebben, and A.J. Collins Hemoglobin level variability: anemia management among variability groups Am J Nephrol 30 6 2009 491 498
23. T. Patel, A. Hirter, J. Kaufman, S.R. Keithi-Reddy, D. Reda, and A. Singh Route of epoetin administration influences hemoglobin variability in hemodialysis patients Am J Nephrol 29 6 2009 532 537
24. A.L. de Francisco, P. Stenvinkel, and S. Vaulont Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness NDT Plus 2 suppl 1 2009 i18 i26
25. CMS 2008 Annual Report, End Stage Renal Disease Clinical Performance Measures Project 2008 Department of Health and Human Services, Office of Clinical Standards & Quality Baltimore, MD
26. US Renal Data System USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2009 National Institutes of Health National Institute of Diabetes and Dialysis and Kidney Disease Bethesda, MD
27. Arbor Research Collaborative for Health 2009 Annual Report of the Dialysis Outcomes and Practice Patterns Study: Hemodialysis Data 1999-2008 2009 Ann Arbor, MI
28. K. Chan, J. Moran, M. Hlatky, and R. Lafayette Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients Nephrol Dial Transplant 24 6 2009 1956 1962
29. Centers for Medicare & Medicaid Services Medicare Program Changes to the hospital outpatient prospective payment system and calendar year 2005 rates; final rule. 42 CFR part 419 Fed Register 69 2004 65681 66234
30. R.L. Pisoni, J.L. Bragg-Gresham, E.W. Young, T. Akizawa, Y. Asano, and F. Locatelli Anemia management outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 44 1 2004 94 131
31. T. Akizawa, R.L. Pisoni, T. Akiba, A. Saito, S. Fukuhara, and Y. Asano Japanese hemodialysis anemia management practices and outcomes (1999-2006): Results from the DOPPS Nephrol Dial Transplant 23 11 2008 3643 3653
32. P.A. McFarlane, R.L. Pisoni, M.A. Eichleay, R. Wald, F.K. Port, and D. Mendelssohn International trends in erythropoietin use and hemoglobin levels in hemodialysis patients Kidney Int 78 2 2010 215 223